My expertise is blood cancer, specifically multiple myeloma (bone marrow cancer). But I follow therapy innovation for other blood cancers, too; often the same drugs–sometimes in a different combination or with a tweak here or there–work for myeloma, too.
This is good news for those of us bone marrow/blood cancer victims who seem caught-up in perpetual chemotherapy. “They” call it maintenance. It’s expensive and there seems to be very little motivation to back-off or stop.
Reuters ran this leukemia related story yesterday:
Test Designed to Screen Resistance to Cancer Drug
Thursday, July 29, 2010
Here is a story about an uplifting study we found on the Leukemia/Lymphoma Society Website: